Loading... info@pharmareview.com +44 (0)20 8123 8474 copyreview pharmareference processdesign about us Controversy over change to single final signatory January 26, 2016 4,292 Views 2016 Code – Controversy over change to single final signatory. Our thoughts on the changes to the 2016 code, specifically what the change to single signatory means for the industry and how that might effect you. (opens in a new tab) We get it right first time Accuracy is at the heart of everything that we do. Our checks are rigorous and we take pride in spotting errors first time, every time. We save time, money and stress By reducing rounds of review, we save days of internal and external resource. Project budgets are healthier, timelines improve and working relationships benefit too. We give you confidence You can be sure that your work is error-free. You don’t need to worry about the detail, you can simply collaborate internally and focus on the strategic issues. We work with the best Our team is made up of professional medical information experts and physicians. Leading brands trust us and we’re proud to say that our reputation in the industry is unparalleled. @pharmareviewuk New Resources DIA Conference Poster November 2016 Controversy over change to single final signatory Main Changes to 2015 Code and Constitution PharmaReview 2021 more info terms of use privacy & cookies twitter linkedin contact PharmaReview Ltd, U6 / Building 7, Chiswick Park, London, W4 5YG info@pharmareview.com +44 (0)20 8123 8474 find us on the map copyright © 2021 PharmaReview - design & build CaoutchouC Design Scroll to Top